Tandem Diabetes Care, Inc. (TNDM) News
Track canonical SquawkNews coverage tagged to TNDM, Tandem Diabetes Care, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Tandem Diabetes Care Is Maintained at Buy by Truist Securities
Ratings actions from Benzinga: GMT) Tandem Diabetes Care Price Target Cut to $28.00/Share From $31.00 by Truist SecuritiesRatings actions from Benzinga
NEWS | Sep 24, 2026, 04:17 PM UTC
L
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughl
REGULATION | Sep 23, 2026, 08:42 PM UTC
M
Tandem Diabetes upgrades to Outperform at WBLR
TNDM is marked new Outperform at WBLR, with no catalyst, price target, or additional details supplied in the alert.
EQUITY | Aug 21, 2026, 12:33 PM UTC
L
TNDM initiated Outperform at William Blair
William Blair initiated coverage of TNDM with an Outperform rating, according to Hammerstone MarketTalk; no additional price target or catalyst was provided.
EQUITY | Aug 21, 2026, 11:58 AM UTC
H
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Airsculpt Technologies Inc (NASDAQ: AIRS ) fell sharply in pre-market trading following second-quarter results. Ai
EARNINGS | Aug 10, 2026, 12:02 PM UTC
L
Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.074B Est
Tandem Diabetes Care (NASDAQ: TNDM ) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.074 billion estimate.
EARNINGS | Aug 06, 2026, 08:23 PM UTC
H
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: UBS upgraded Intuitive Surgical (I
EARNINGS | Jul 28, 2026, 01:35 PM UTC
L
BBNX (Buy, $22 PT), DXCM (Buy, $96 PT), PODD (Neutral, $174 PT), TNDM (Neutral, $18 PT) resuming coverage in the Diabetes sector – initiate
BBNX (Buy, $22 PT), DXCM (Buy, $96 PT), PODD (Neutral, $174 PT), TNDM (Neutral, $18 PT) resuming coverage in the Diabetes sector – initiate MMED @ UBS
EQUITY | Jul 28, 2026, 11:50 AM UTC
L
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
EQUITY | Jul 28, 2026, 11:47 AM UTC